Select Page
Leslie Street, Ph.D.

Leslie Street, Ph.D.

Dr Street received his PhD in organic chemistry from the University of Leeds in the UK and then did postdoctoral studies, in synthetic organic chemistry, at the University of California, Los Angeles. Leslie joined Psychogenics in March 2020 as Vice President, Head of...
Steven C. Leiser, Ph.D.

Steven C. Leiser, Ph.D.

Dr. Leiser has over 10 years of experience in drug discovery and applying translatable neurophysiological biomarkers in diverse drug discovery projects across CNS disorders including schizophrenia, Alzheimer’s, depression, epilepsy. An expert in in vivo...
Afshin Ghavami, Ph.D.

Afshin Ghavami, Ph.D.

Dr. Ghavami joined PsychoGenics in 2007 and directs molecular biology and electrophysiology groups and has been extensively involved in drug discovery research. Dr. Ghavami obtained his Ph.D. in Neuroscience, from Universite de Louis Pasteur in Strasbourg, France, in...
Sylvie Ramboz, Ph.D.

Sylvie Ramboz, Ph.D.

Dr. Sylvie Ramboz received her Ph.D. in Neuropharamacology at the Institute for Genetics and Cellular and Molecular Biology, Strasbourg, France. She has extensive experience in the biotechnology industry, first at Memory Pharmaceuticals, then at Xenogen Biosciences...
Geoff Varty, Ph.D.

Geoff Varty, Ph.D.

Dr. Varty received his GlaxoWellcome-sponsored Ph.D. in Neuropharmacology from the University of Hertfordshire, and post-doctoral training in Psychopharmacology from the University of California, San Diego. He is the EVP for Research Operations at PsychoGenics Inc., a...